Skip to content

Clinical trials

Pancreatic Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Country / region: China Clear all

539 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20051
20071
20082
20106
20127
201311
201412
201518
201626
201718
201826
201939
202031
202133
202240
202359
202491
202565
202649

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status187
Recruiting168
Completed89
Not yet recruiting54
Active, not recruiting18
Terminated13
Withdrawn6
Enrolling by invitation2
No longer available1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University43
Changhai Hospital27
Peking Union Medical College Hospital27
Ruijin Hospital20
Tianjin Medical University Cancer Institute and Hospital20
Zhejiang University16
Second Affiliated Hospital, Zhejiang University, School of Medicine14
RenJi Hospital13
Fuda Cancer Hospital, Guangzhou12
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms539
Stomach Neoplasms57
Colorectal Neoplasms53
Breast Neoplasms37
Lung Neoplasms37
Ovarian Neoplasms31
Esophageal Neoplasms28
Liver Neoplasms24
Neoplasms23
Carcinoma, Non-Small-Cell Lung20

Trials

Showing 76 to 100 of 539. Each trial links to its page on Pharma Observatory.

439 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.